Results 191 to 200 of about 7,776 (285)

O USO DO NUSINERSEN NO TRATAMENTO DA ATROFIA MUSCULAR ESPINHAL: REVISÃO DE LITERATURA

, 2020
Elzanice Monteiro DOMINGOS, Annalu Moreira Aguiar   +1 more
openalex   +2 more sources

Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study

, 2022
Lauren Elman, Bora Youn, Crystal M. Proud, Margaret R. Frey, Senda Ajroud‐Driss, Mary McCormick, David Michelson, Michael S. Cartwright, Terry Heiman‐Patterson, Joseph M. Choi, Aastha Chandak, Artak Khachatryan, Marta Martínez‐Avilés, Angela D. Paradis   +13 more
openalex   +2 more sources

Nusinersen Use in Spinal Muscular Atrophy [PDF]

Pediatrics, 2019
openaire   +2 more sources

A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States [PDF]

, 2017
Clarke, Angus John, Ross, Lainie Friedman   +1 more
core   +2 more sources

Novel Complication of Nusinersen Treatment: Hyponatremia [PDF]

Journal of Clinical Intensive Care and Medicine, 2018
openaire   +1 more source

Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers. [PDF]

Front Neurol
Sun Y, Li W, Cui X, Li Y, Gao X, Fu D, Zhao X, Cao T, Zhu M.   +8 more
europepmc   +1 more source

Serum creatinine to cystatin C ratio as monitoring biomarker in Chinese adult spinal muscular atrophy: a prospective cohort study. [PDF]

Orphanet J Rare Dis
Chen S, Wang Q, Fu J, Wei Q, Ou R, Lai X, Chen X, Shang H.   +7 more
europepmc   +1 more source

Nusinersen and spinal muscular atrophies: Where are we in 2020?

Annals of Indian Academy of Neurology, 2020
Rakesh K. Singh, Satish V Khadilkar
openaire   +4 more sources

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands. [PDF]

Eur J Health Econ
van der Schans S, Velikanova R, Weidlich D, Howells R, Patel A, Bischof M, Postma MJ, Boersma C.   +7 more
europepmc   +1 more source

Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. [PDF]

Diagnostics (Basel)
Iketani K, Awano H, Hashimura H, Sonehara S, Hanafusa H, Nambu Y, Nishio H, Nozu K, Bo R.   +8 more
europepmc   +1 more source